SCHEMBL3556448

SCHEMBL3556448

CN(C)CCOc1c[nH]c2c(Cl)cc(Cl)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
NR4A2 P43354 4/20 0.38
SLC6A4 P31645 1/20 0.38
KDM4E B2RXH2 5/20 0.38
MAPK1 P28482 3/20 0.38
GAA P10253 1/20 0.38
CSF1R P07333 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTR1B P28222 1/20 0.37
HPGD P15428 2/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3563397 0.86 MAPT (0.45) MAPTCHRNB2CHRNA4NR4A2KDM4E
SCHEMBL3558681 0.77 SLC6A4 (0.57) MAPTCHRNB2CHRNA4NR4A2SLC6A4
SCHEMBL3554200 0.74 HTR7 (0.45) MAPTSLC6A4KDM4EHTR1BALDH1A1
SCHEMBL3562128 0.74 SLC6A4 (0.57) MAPTCHRNB2CHRNA4NR4A2SLC6A4
SCHEMBL3561474 0.73 MAPT (0.46) MAPTCHRNB2CHRNA4NR4A2KDM4E
SCHEMBL27942658 0.69 SLC22A6 (0.46) MAPTNR4A2KDM4EGAATDP1
SCHEMBL3558501 0.68 PDE10A (0.41) MAPTSLC6A4KDM4ECSF1RTDP1
SCHEMBL3555909 0.67 HTR1B (0.55) SLC6A4KDM4EHTR1BALDH1A1CYP3A4
SCHEMBL3560720 0.66 MAPT (0.41) MAPTNR4A2KDM4EMAPK1GAA
SCHEMBL3563897 0.66 SLC6A4 (0.57) NR4A2SLC6A4KDM4ETDP1HTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT MAPT 1145/4885CHRNB2 1194/4885CHRNA4 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.